20960212 27558558 25448752 25342915 29022053 32540391 34015285 27568833 23624335 25376947 27671971 28277032 - Search Results

Year	Number of Results
2010	1
2012	1
2013	1
2014	3
2015	1
2016	3
2017	3
2018	1
2020	1
2021	1
2022	0

1

Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.

Schalkwijk CG, Miyata T. Schalkwijk CG, et al. Amino Acids. 2012 Apr;42(4):1193-204. doi: 10.1007/s00726-010-0779-9. Epub 2010 Oct 20. Amino Acids. 2012. PMID: 20960212 Free PMC article. Review.

2

Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Pichler R, Afkarian M, Dieter BP, Tuttle KR. Pichler R, et al. Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F716-F731. doi: 10.1152/ajprenal.00314.2016. Epub 2016 Aug 24. Am J Physiol Renal Physiol. 2017. PMID: 27558558 Free PMC article. Review.

3

Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.

Lv M, Chen Z, Hu G, Li Q. Lv M, et al. Drug Discov Today. 2015 Mar;20(3):332-46. doi: 10.1016/j.drudis.2014.10.007. Epub 2014 Oct 31. Drug Discov Today. 2015. PMID: 25448752 Review.

4

Diabetic nephropathy - complications and treatment.

Lim AKh. Lim AKh. Int J Nephrol Renovasc Dis. 2014 Oct 15;7:361-81. doi: 10.2147/IJNRD.S40172. eCollection 2014. Int J Nephrol Renovasc Dis. 2014. PMID: 25342915 Free PMC article. Review.

5

Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation.

Roohk HV, Zaidi AR, Patel D. Roohk HV, et al. Inflamm Res. 2018 Jan;67(1):21-30. doi: 10.1007/s00011-017-1089-4. Epub 2017 Oct 11. Inflamm Res. 2018. PMID: 29022053 Review.

6

Stochastic non-enzymatic modification of long-lived macromolecules - A missing hallmark of aging.

Fedintsev A, Moskalev A. Fedintsev A, et al. Ageing Res Rev. 2020 Sep;62:101097. doi: 10.1016/j.arr.2020.101097. Epub 2020 Jun 12. Ageing Res Rev. 2020. PMID: 32540391 Free article. Review.

7

Diabetic nephropathy: A twisted thread to unravel.

Dagar N, Das P, Bisht P, Taraphdar AK, Velayutham R, Arumugam S. Dagar N, et al. Life Sci. 2021 Aug 1;278:119635. doi: 10.1016/j.lfs.2021.119635. Epub 2021 May 17. Life Sci. 2021. PMID: 34015285 Review.

8

Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update.

Bhattacharjee N, Barma S, Konwar N, Dewanjee S, Manna P. Bhattacharjee N, et al. Eur J Pharmacol. 2016 Nov 15;791:8-24. doi: 10.1016/j.ejphar.2016.08.022. Epub 2016 Aug 25. Eur J Pharmacol. 2016. PMID: 27568833 Review.

9

Clinical, pathophysiological and structure/function consequences of modification of albumin by Amadori-glucose adducts.

Cohen MP. Cohen MP. Biochim Biophys Acta. 2013 Dec;1830(12):5480-5. doi: 10.1016/j.bbagen.2013.04.024. Epub 2013 Apr 23. Biochim Biophys Acta. 2013. PMID: 23624335 Review.

10

Novel effective drugs for diabetic kidney disease? or not?

Gentile G, Mastroluca D, Ruggenenti P, Remuzzi G. Gentile G, et al. Expert Opin Emerg Drugs. 2014 Dec;19(4):571-601. doi: 10.1517/14728214.2014.979151. Epub 2014 Nov 7. Expert Opin Emerg Drugs. 2014. PMID: 25376947 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results